FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,589,773 | -23.7% | 333,986 | -8.6% | 0.04% | -26.3% |
| Q1 2023 | $2,082,700 | +7.5% | 365,386 | +90.4% | 0.06% | +3.6% |
| Q4 2022 | $1,936,644 | +37.4% | 191,937 | +205.2% | 0.06% | +10.0% |
| Q3 2022 | $1,409,000 | +552.3% | 62,888 | +621.2% | 0.05% | +400.0% |
| Q2 2022 | $216,000 | -76.4% | 8,720 | -43.5% | 0.01% | -86.3% |
| Q3 2021 | $914,000 | -18.0% | 15,428 | +14.1% | 0.07% | -28.4% |
| Q1 2021 | $1,114,000 | +10.8% | 13,516 | +22.3% | 0.10% | -3.8% |
| Q4 2020 | $1,005,000 | +53.9% | 11,055 | -66.9% | 0.11% | +171.8% |
| Q4 2019 | $653,000 | +264.8% | 33,373 | +81.7% | 0.04% | +225.0% |
| Q1 2018 | $179,000 | – | 18,369 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |